Market Research Logo

North America Intrauterine Contraceptive Device Market Forecast 2017-2025

North America Intrauterine Contraceptive Device Market Forecast 2017-2025

KEY FINDINGS
The North America Intrauterine contraceptive device market was estimated to be at $863 million in 2016. The market is predicted to rise over the forecast period of 2017-2025 at a CAGR of 3.37%, generating $1156 million by the end of 2025.

MARKET INSIGHTS
The market is being presented with opportunities like a high rate of unintended pregnancies, teen pregnancies, abortions, etc. across the region. The fact that these devices have a very low failure rate or side effects as compared to other contraceptive methods are increasing their popularity in the region. However, factors like limited access to contraceptives for the youths or the poor sections of the society coupled with the possible risks or infertility issues associated with these devices might restrain the market advancement in the future.

COMPETITIVE INSIGHTS
AllerganPlc, Pregna, HLL Lifecare Limited, Egemen International, Ocon Medical Ltd, SMB Corporation, Medisafe Distribution Inc, Pfizer, Melbea, Merck &Co, Trimedic Supply Network Ltd, Meril Life Sciences Private Limited, Teva Pharmaceutical Industries Limited, Bayers Ag,etc are some of the prominent players in the market.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
4. Market Determinants
4.1. Drivers
4.1.1. Better Technology In Iud Making Them Safer And Effective
4.1.2. Long Term Use Makes Them A Popular Choice
4.1.3. Health Benefits
4.1.4. Increase In Government Initiatives To Avoid Unsolicited Pregnancies And Abortions
4.2. Market Restraints
4.2.1. Limited Access To Contraceptives For The Youths, Unmarried People, And Poorer Segments Of The Society
4.2.2. Infertility Issues And Other Risks Associated With Intrauterine Contraceptive Device
4.3. Opportunities
4.3.1. Occurrence Of Strong Contraceptive Pipeline
4.3.2. Rate Of Unintended Pregnancies Is Very High
4.3.3. Very Low Failure Rate Of Iud And Low Side Effects
4.4. Challenges
4.4.1. Risk Of Instigating Pelvic Inflammatory Infection (Pid)
4.4.2. High Risk Of Ectopic Pregnancy
5. Market Segmentation
5.1. Market By Type 2017-2025
5.1.1. Copper Intrauterine Device
5.1.2. Hormonal Intrauterine Device
5.2. Market By Product 2017-2025
5.2.1. Mirena
5.2.2. Skyla Market
5.2.3. Paragard
5.2.4. Other Products Market
6. Key Analytical
6.1. Porter’s Five Force Model
6.1.1. Threat Of New Entrants
6.1.2. Threats Of Substitute Product
6.1.3. Bargaining Power Of Buyer
6.1.4. Bargaining Power Of Supplier
6.1.5. Intensity Of Competitive Rivalry
6.2. Value Chain Analysis
6.3. Legal, Policy And Regulatory Framework
6.4. Opportunity Matrix
6.5. Key Market Players
6.6. Key Buying Criteria
7. Geographical Analysis
7.1. North America
7.1.1. United States
7.1.2. Canada
8. Competitive Landscape
8.1. Key Strategies
9. Company Profiles
9.1. Competitive Strategy
9.2. Market Share Analysis
9.3. Allergan, Plc
9.4. Bayers Ag
9.5. Dkt International
9.6. Egemen International
9.7. Hll Lifecare Limited
9.8. Krishco Medical Products Pvt.Ltd
9.9. Medisafe Distribution, Inc.
9.10. Meril Life Sciences Private Limited
9.11. Merck & Co.
9.12. Melbea
9.13. Mona Lisa N.V
9.14. Ocon Medical Ltd
9.15. Okamoto Industries, Inc
9.16. Pfizer
9.17. Pregna
9.18. Smb Corporation
9.19. Teva Pharmaceutical Industries Limited
9.20. Trimedic Supply Network Ltd
9.21. Zhejiang Daji Medical Instruments Co., Ltd.
Table List
Table 1 North America Intrauterine Contraceptive Device Market 2017-2025 ($ Million)
Table 2 Birth Control Methods And Their Failure Rates
Table 3 Product Pipeline In Intrauterine Contraceptive Devices
Table 4 Birth Control Methods And Their Failure Rates
Table 5 Usage Of Iud Device In Terms Of Types
Table 6 Pros & Cons Of Intrauterine Devices
Table 7 North America Intrauterine Contraceptive Device (Iud) Market By Type 2017-2025 ($ Million)
Table 8 Fda Approved Contraceptive Methods For Women
Table 9 North America Copper Intrauterine Device Market 2017-2025 ($ Million)
Table 10 North America Hormonal Intrauterine Device Market 2017-2025 ($ Million)
Table 11 North America Intrauterine Contraceptive Device Market By Product 2017-2025($ Million)
Table 12 North America Mirena Market 2017-2025
Table 13 North America Skyla Market 2017-2025 ($ Million)
Table 14 North America Paragard Market 2017-2025($ Million)
Table 15 North America Other Product Market 2017-2025 ($ Million)
Table 16 North America Intrauterine Contraceptive Device Market 2017-2025 ($ Million)
Figure List
Figure 1 Reasons For Not Preferring Consumable Contraceptives Among Women
Figure 2 North America Copper Intrauterine Device Market 2017-2025 ($ Million)
Figure 3 North America Hormonal Intrauterine Device Market 2017-2025 ($ Million)
Figure 4 North America Mirena Market 2017-2025 ($ Million)
Figure 5 North America Skyla Market 2017-2025 ($ Million)
Figure 6 North America Paragard Market 2017-2025($ Million)
Figure 7 North America Other Products Market 2017-2025 ($ Million)
Figure 8 Value Chain Analysis Of Intrauterine Contraceptive Market
Figure 9 Effectivity Of Various Iuds
Figure 10 Possible Side Effects Of Iud
Figure 11 United States Intrauterine Contraceptive Device Market 2017-2025 ($ Million)
Figure 12 Canada Intrauterine Contraceptive Device Market 2017-2025 ($ Million)
Figure 13 Global Iucd Top Companies Market Share 2016 (In %)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report